The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
HIV/AIDS Treatment

Basics & Resources Basics & Resources

To learn more about each of the HIV meds that U.S. guidelines list as potential first-line drugs, browse this page or pick from the list below:

Ask The Experts

Keeping an HIV Treatment HistoryKeeping an HIV Treatment History

Any treatment choice for your future care is closely linked to your previous treatment history. Keeping your own records helps you work with providers to get the best care possible, even if you're just starting treatment.

6 Reasons Why People Skip Their HIV Meds6 Reasons Why People Skip Their HIV Meds

Taking HIV medications every day isn't the easiest thing to do. We'll help you through some of the obstacles that everyday life brings.

Getting HIV Drugs in the U.S.

Learn about many options for getting HIV drugs in the U.S.: private insurers, ACA marketplaces, ADAP, Medicaid, Medicare, and more.

What Can We Learn From HIV-Positive Patients Who Control the Virus After Stopping Treatment?
Matthew Perkins, M.D, discusses the interest in post-treatment controllers -- people living with HIV who are able to control the virus for a period of time after stopping therapy -- and the first study such individuals.

What's the Next Big Question in HIV Treatment?
Now that a major study has confirmed the overwhelming benefits of starting treatment immediately for all living with HIV -- what's the next big question in HIV treatment?

Long-Acting Injectable HIV Treatment Shows Promise in Early Study Results
A future of HIV treatment that doesn't depend on daily dosing seemed to move a little closer today. Early study results support an injected combination of two antiretrovirals given monthly or every two months.

Developing Multi-Pronged Antibodies to Target the HIV Reservoir
Three studies describe a new strategy for depleting the HIV reservoir by engineering antibodies or antibody-like molecules which are capable of simultaneously binding two targets.

Read more in's newsroom >>